192 related articles for article (PubMed ID: 11232945)
1. Impact of boost technique on outcome in early-stage breast cancer patients treated with breast-conserving therapy.
Frazier RC; Kestin LL; Kini V; Martinez AA; Chen PY; Baglan KL; Vicini FA
Am J Clin Oncol; 2001 Feb; 24(1):26-32. PubMed ID: 11232945
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome with interstitial brachytherapy in the management of patients with early-stage breast cancer treated with breast-conserving therapy.
Vicini FA; Horwitz EM; Lacerna MD; Dmuchowski CF; Brown DM; White J; Chen PY; Edmundson GK; Gustafson GS; Clarke DH; Gustafson GS; Matter RC; Martinez AA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):845-52. PubMed ID: 9128961
[TBL] [Abstract][Full Text] [Related]
3. The use of iodine-125 seeds as a substitute for iridium-192 seeds in temporary interstitial breast implants.
Vicini F; White J; Gustafson G; Matter RC; Clarke DH; Edmundson G; Martinez A
Int J Radiat Oncol Biol Phys; 1993 Oct; 27(3):561-6. PubMed ID: 8226149
[TBL] [Abstract][Full Text] [Related]
4. A comparison of a brachytherapy and an external beam radiotherapy boost in breast-conserving therapy for breast cancer: local and any recurrences.
Kindts I; Verhoeven K; Laenen A; Christiaens M; Janssen H; Van der Vorst A; Van Limbergen E; Weltens C
Strahlenther Onkol; 2019 Apr; 195(4):310-317. PubMed ID: 30603857
[TBL] [Abstract][Full Text] [Related]
5. Brachytherapy or electron beam boost in conservation therapy of carcinoma of the breast: a nonrandomized comparison.
Perez CA; Taylor ME; Halverson K; Garcia D; Kuske RR; Lockett MA
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):995-1007. PubMed ID: 8600112
[TBL] [Abstract][Full Text] [Related]
6. External beam irradiation plus (192)Ir implant after breast-preserving surgery in women with early breast cancer.
Moreno F; Guedea F; Lopez Y; Ferrer F; Gutierrez C; Petriz L; Pera J
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):757-65. PubMed ID: 11020573
[TBL] [Abstract][Full Text] [Related]
7. Early breast cancer: influence of type of boost (electrons vs iridium-192 implant) on local control and cosmesis after conservative surgery and radiation therapy.
Touboul E; Belkacemi Y; Lefranc JP; Uzan S; Ozsahin M; Korbas D; Buffat L; Balosso J; Pene F; Blondon J
Radiother Oncol; 1995 Feb; 34(2):105-13. PubMed ID: 7597208
[TBL] [Abstract][Full Text] [Related]
8. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
[TBL] [Abstract][Full Text] [Related]
9. Low-dose-rate brachytherapy as the sole radiation modality in the management of patients with early-stage breast cancer treated with breast-conserving therapy: preliminary results of a pilot trial.
Vicini FA; Chen PY; Fraile M; Gustafson GS; Edmundson GK; Jaffray DA; Benitez P; Pettinga J; Madrazo B; Ingold JA; Goldstein NS; Matter RC; Martinez AA
Int J Radiat Oncol Biol Phys; 1997 May; 38(2):301-10. PubMed ID: 9226316
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
[TBL] [Abstract][Full Text] [Related]
11. Long-term clinical and cosmetic outcomes after breast conservation treatment for women with early-stage breast carcinoma according to the type of breast boost.
Hill-Kayser CE; Chacko D; Hwang WT; Vapiwala N; Solin LJ
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1048-54. PubMed ID: 20510548
[TBL] [Abstract][Full Text] [Related]
12. IORT with electrons as boost strategy during breast conserving therapy in limited stage breast cancer: long term results of an ISIORT pooled analysis.
Fastner G; Sedlmayer F; Merz F; Deutschmann H; Reitsamer R; Menzel C; Stierle C; Farmini A; Fischer T; Ciabattoni A; Mirri A; Hager E; Reinartz G; Lemanski C; Orecchia R; Valentini V
Radiother Oncol; 2013 Aug; 108(2):279-86. PubMed ID: 23830467
[TBL] [Abstract][Full Text] [Related]
13. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
[TBL] [Abstract][Full Text] [Related]
14. Clinical and cosmetic results of breast boost radiotherapy in early breast cancer: a randomized study between electron and photon.
Rajan SS; Sharma SC; Kumar N; Kumar R; Singh G; Singh R; Tomar P
J Cancer Res Ther; 2014; 10(4):889-95. PubMed ID: 25579524
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
[TBL] [Abstract][Full Text] [Related]
16. Ductal carcinoma in situ detected in the mammographic era: an analysis of clinical, pathologic, and treatment-related factors affecting outcome with breast-conserving therapy.
Vicini FA; Lacerna MD; Goldstein NS; Horwitz EM; Dmuchowski CF; White JR; Gustafson GS; Ingold JA; Martinez AA
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):627-35. PubMed ID: 9336142
[TBL] [Abstract][Full Text] [Related]
17. Mammographic, pathologic, and treatment-related factors associated with local recurrence in patients with early-stage breast cancer treated with breast conserving therapy.
Kini VR; Vicini FA; Frazier R; Victor SJ; Wimbish K; Martinez AA
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):341-6. PubMed ID: 10030259
[TBL] [Abstract][Full Text] [Related]
18. IOERT versus external beam electrons for boost radiotherapy in stage I/II breast cancer: 10-year results of a phase III randomized study.
Ciabattoni A; Gregucci F; Fastner G; Cavuto S; Spera A; Drago S; Ziegler I; Mirri MA; Consorti R; Sedlmayer F
Breast Cancer Res; 2021 Apr; 23(1):46. PubMed ID: 33849606
[TBL] [Abstract][Full Text] [Related]
19. Long term results with breast-conserving therapy for patients with early stage breast carcinoma in a community hospital setting.
Kini VR; White JR; Horwitz EM; Dmuchowski CF; Martinez AA; Vicini FA
Cancer; 1998 Jan; 82(1):127-33. PubMed ID: 9428488
[TBL] [Abstract][Full Text] [Related]
20. A cosmetic evaluation of breast cancer treatment: a randomized study of radiotherapy boost technique.
Vass S; Bairati I
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1274-82. PubMed ID: 16029782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
